Stockscreener 앱 받기
44.90
2.10%
0.925
시장 영업 전:
45.00
0.105
+0.23%
Dianthus Therapeutics Inc 주식(DNTH)의 최신 뉴스
27,003 Shares in Dianthus Therapeutics, Inc. $DNTH Bought by XTX Topco Ltd - MarketBeat
Geode Capital Management LLC Has $9.04 Million Stock Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Can Dianthus Therapeutics Inc. (87E) stock sustain breakout momentum2025 AllTime Highs & Detailed Earnings Play Alerts - Newser
Is Dianthus Therapeutics Inc. (87E) stock a contrarian opportunityWeekly Loss Report & Real-Time Volume Analysis - Newser
Dianthus Therapeutics stock hits 52-week high at 45.0 USD - Investing.com
Can Dianthus Therapeutics Inc. (87E) stock deliver double digit returnsPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - Newser
Will Dianthus Therapeutics Inc. (87E) stock outperform value peersTrade Risk Assessment & Low Risk High Reward Ideas - Newser
Dianthus Therapeutics, Inc. $DNTH Shares Bought by Sio Capital Management LLC - MarketBeat
CapEx per share of Dianthus Therapeutics, Inc. – TRADEGATE:87E - TradingView
DNTH: Advancing two autoimmune therapies with strong clinical data and $525M cash runway - TradingView
Ensign Peak Advisors Inc Invests $2.50 Million in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Stocks of Dianthus Therapeutics Inc (DNTH) are poised to climb above their peers - Setenews
Fed fueled market rally dnth breakout setup and ethereums critical test zone ahead | Fundamental analysis - RichTv
Dianthus Therapeutics (NASDAQ:DNTH) Reaches New 52-Week HighShould You Buy? - MarketBeat
Avidity Partners Management LP Reduces Stake in Dianthus Therape - GuruFocus
What analysts say about Dianthus Therapeutics Inc stockStock Buy Signals & Top Analyst Picks Available for Free - earlytimes.in
Dianthus Therapeutics stock hits 52-week high at 43.69 USD By Investing.com - Investing.com Nigeria
Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Dianthus Therapeutics (Nasdaq: DNTH) joins 8th Evercore Healthcare Conference on Dec. 2 - Stock Titan
The Insider Report: Prepare for the Next Dip Buying Opportunity - Benzinga
DNTH SEC FilingsDianthus Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Wedbush Maintains Dianthus Therapeutics (DNTH) Outperform Recommendation - MSN
How forex fluctuations impact Dianthus Therapeutics Inc. (87E) stockPortfolio Gains Summary & Safe Capital Growth Trade Ideas - newser.com
Why Dianthus Therapeutics Inc. stock remains resilient2025 Short Interest & Real-Time Volume Triggers - newser.com
How Dianthus Therapeutics Inc. (87E) stock performs in easing cyclesCEO Change & Daily Entry Point Alerts - newser.com
How Dianthus Therapeutics Inc. stock reacts to global recession fearsJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
Views of Wall Street’s Leading Experts on Dianthus Therapeutics Inc - Setenews
Smart tools for monitoring Dianthus Therapeutics Inc.’s price action2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
What analysts say about Dianthus Therapeutics Inc 87E stock - earlytimes.in
How to escape a deep drawdown in Dianthus Therapeutics Inc.Earnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com
Dianthus Therapeutics (NASDAQ:DNTH) EVP Sells $3,221,132.67 in Stock - Defense World
Candriam S.C.A. Has $4.48 Million Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Dianthus Therapeutics Insider Sold Shares Worth $7,379,887, According to a Recent SEC Filing - MarketScreener
Dianthus Therapeutics (NASDAQ:DNTH) Hits New 12-Month High – Here’s Why - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) EVP Simrat Randhawa Sells 109,031 Shares - MarketBeat
Insider Selling: Dianthus Therapeutics (NASDAQ:DNTH) EVP Sells 87,507 Shares of Stock - MarketBeat
What dividend safety score for Dianthus Therapeutics Inc. stock2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Dianthus Therapeutics (NASDAQ:DNTH) Sets New 1-Year HighWhat's Next? - MarketBeat
Will Dianthus Therapeutics Inc. (87E) stock hit Wall Street targetsWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
Can Dianthus Therapeutics Inc. stock hit analyst price targetsEarnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com
Dianthus Therapeutics Stock (DNTH) Opinions on Recent Price Surge and Clinical Trial Results - Quiver Quantitative
Is Dianthus Therapeutics Inc. (87E) stock a fit for income portfoliosNew Guidance & Safe Entry Point Identification - newser.com
What recovery options are there for Dianthus Therapeutics Inc.July 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
1.10%
1.10%
자본화:
|
볼륨(24시간):